Genetic Prediction of Lifetime Risk of Fracture
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad254 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Thao P Ho-Le und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia. Hauptthemen laut MEDLINE: Osteoporosis, Hip Fractures, Osteoporotic Fractures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Context
Fragility fracture is a significant public health problem because it is associated with increased mortality. We want to find out whether the risk of fracture can be predicted from the time of birth.
Objective
To examine the association between a polygenic risk score (PRS) and lifetime fracture risk.
Methods
This population-based prospective study involved 3515 community-dwelling individuals aged 60+ years who have been followed for up to 20 years. Femoral neck bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry. A PRS was created by summing the weighted number of risk alleles for each single nucleotide polymorphism using BMD-associated coefficients. Fragility fractures were radiologically ascertained, whereas mortality was ascertained through a state registry. Residual lifetime risk of fracture (RLRF) was estimated by survival analysis.
Results
The mortality-adjusted RLRF for women and men was 36% (95% CI, 34%-39%) and 21% (18%-24%), respectively. Individuals with PRS > 4.24 (median) had a greater risk (1.2-fold in women and 1.1-fold in men) than the population average risk. For hip fracture, the average RLRF was 10% (95% CI, 8%-12%) for women and ∼5% (3%-7%) for men; however, the risk was significantly increased by 1.5-fold and 1.3-fold for women and men with high PRS, respectively.
Conclusion
A genetic profiling of BMD-associated genetic variants is associated with the residual lifetime risk of fracture, suggesting the potential for incorporating the polygenic risk score in personalized fracture risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia.
- Skeletal Disease Group, Garvan Institute of Medical Research, Sydney, NSW 2010, Australia.
- School of Medicine Sydney, University of Notre Dame Australia, Sydney, NSW 2010, Australia.
- School of Population Health, UNSW Medicine, UNSW, Sydney 2033, Australia.
ORCID-Profile: Thach S Tran, Jacqueline R Center, Tuan V Nguyen
Zitieren
APA
Ho-Le, T. P., Tran, T. S., Nguyen, H. G., Center, J. R., Eisman, J. A., & Nguyen, T. V. (2023). Genetic Prediction of Lifetime Risk of Fracture. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad254
Vancouver
Ho-Le TP, Tran TS, Nguyen HG, Center JR, Eisman JA, Nguyen TV. Genetic Prediction of Lifetime Risk of Fracture. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad254
BibTeX
@article{HoLe2023,
author = {Ho-Le, Thao P and Tran, Thach S and Nguyen, Huy G and Center, Jacqueline R and Eisman, John A and Nguyen, Tuan V},
title = {Genetic Prediction of Lifetime Risk of Fracture},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad254}
}
EUVIMED